Globalization

GVK HQ in Hyderabad - no new contracts since last August

Europe's response "disproportionate" says GVK Biosciences

By Gareth Macdonald

GVK Biosciences has called marketing authorisation withdrawals by various European regulators “disproportionate,” arguing that ECG results at centre of data manipulation investigation have no bearing on safety.

Follow us

Products

View more

Webinars